Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ANIX
Stock Latest News
Ratings
Anixa Biosciences Receives Buy Rating Amidst Strong Patent Portfolio and Promising Vaccine Trials
2d ago
ANIX
Premium
The Fly
Anixa Biosciences awarded new U.S. patent for breast cancer technology
2d ago
ANIX
Premium
Ratings
Positive Outlook for Anixa Biosciences: Patent Secures Ovarian Cancer Vaccine and Promising CAR-T Therapy Progress
16d ago
ANIX
Premium
The Fly
Anixa announces issuance of additional USPTO for ovarian cancer vaccine tech
17d ago
ANIX
Premium
Ratings
Positive Outlook for Anixa Biosciences: Promising Cancer Treatment Trials Justify Buy Rating
1M ago
ANIX
Premium
The Fly
Anixa initiates dosing in fourth cohort of ovarian cancer CAR-T trial
1M ago
ANIX
Premium
The Fly
Anixa Biosciences announces poster presentation on Ovarian cancer CAR-T trial
2M ago
ANIX
Premium
Ratings
Promising Developments at Anixa Biosciences: Buy Rating Reiterated with $7 Price Target
2M ago
ANIX
Premium
The Fly
Anixa Biosciences completes enrollment in Phase 1 trial of breast cancer vaccine
2M ago
ANIX
Premium
The Fly
Anixa Biosciences receives notice of allowance for new patent from USPTO
3M ago
ANIX
Premium
The Fly
Anixa Biosciences receives notice of allowance for new patent from USPTO
4M ago
ANIX
Premium
Ratings
Innovative Oncology Approaches and Strategic Partnerships Drive Buy Rating for Anixa Biosciences
4M ago
ANIX
Premium
The Fly
Anixa Biosciences to develop AI-guided cancer vaccines with Verdi Solutions
4M ago
ANIX
Premium
Ratings
Anixa Biosciences: Buy Rating Affirmed Amid Patent Approval and Clinical Trial Advancements
4M ago
ANIX
Premium
The Fly
Anixa receives notice of allowance from USPTO for ovarian cancer vaccine
4M ago
ANIX
Premium
Company Announcements
Anixa Biosciences Holds Annual Stockholder Meeting 2025
4M ago
8K
ANIX
Premium
The Fly
Anixa Biosciences initiated with a Buy at Maxim
4M ago
ANIX
Premium
The Fly
Anixa doses first patient in third cohort of Phase 1 clinical trial of CAR-T
5M ago
ANIX
Premium
Ratings
Anixa Biosciences: Advancing CAR-T Therapy and Cancer Vaccines with Strategic Trial Amendments and Robust Financial Position
5M ago
ANIX
Premium
The Fly
Anixa Biosciences announces approval of protocol amendment for CAR-T trial
5M ago
ANIX
Premium
Company Announcements
Director Shows Confidence in Anixa Biosciences with New Stock Purchase
6M ago
ANIX
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
ANIX
ERNA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
